The engine to put transformative therapeutics at our fingertips

Our Mission

Propel drug discovery into the information age to bridge the gap between discovery and treatment

Our Technology

Premium chemical data at unrivaled scale

The first step to powering an engine is to add the right fuel. We’re generating chemical data purpose-built for drug discovery in the information age.

Our closed loop system generates precise chemical datasets at unrivaled scale that work seamlessly with AI to systematically map biochemical interactions between small molecules and causes of disease. With our unparalleled resolution, we’re finally able to meet the challenge of drug discovery with the power of both scale experimentation and modern computation, deriving insights that lead to new drugs for patients in need. Learn more.

The engine to solve hard problems

When it comes to chemistry data, scale and precision are key. Our integrated computational platform, tNova, runs iterative cycles of virtual molecular design and precise biochemical measurement, feeding forward every experiment to power artificial intelligence and machine learning models, which in turn guide the next cycle of design. Learn more.

Our Team

We are a highly skilled, dedicated, and passionate team that combines specific expertise and experience in AI, medicinal chemistry, biology and preclinical development, automation, and nanotechnology, with the bold vision to create a world where transformative therapeutics are available at our fingertips.

Alex Hesselgrave
Alice Liu
Amanda Abdel-Al
Angela Burmayan
Ariadna Chavez
Audrey Vu
Brian Shao
David Khachatrian
Desiree VanHaute
Jonathon Duquette
Justin Provchy
Kathleen Elison
Kevin Shan
Kristin Gauderman
Lydia Cheng
Lillian Tong
Marisa Bowers
Nikola Kenjic
Ricajoy Montero
Robert DeBergh
Rozalina Karapetyan
Sonal Slate
Sydnee Green
Synnove Helset
Taline Mardirossian
Wafa Abidi
Zahid Panjwani
See More Team Members


Terray Therapeutics Strengthens Leadership with Appointment of Sudha Parasuraman, MD to its Board of Directors
Sudha Parasuraman, MD, experienced biotech leader with a strong track record of therapeutic development, joins as Independent Board Director Pasadena, Calif., May 16, 2023 – Read More
Terray Therapeutics Appoints John Maraganore, Ph.D., as Strategic Advisor
John Maraganore, Ph.D., founding CEO of Alnylam Pharmaceuticals and veteran biotech industry leader, joins Terray as Strategic Advisor to the Board of Directors and Leadership Read More
Terray Therapeutics Strengthens Leadership with Appointment of Bassil Dahiyat, Ph.D., as Board Independent Director
Bassil Dahiyat, Ph.D., CEO of Xencor and biotech industry leader, joins the Board of Directors Pasadena, Calif., November 30, 2022 – Terray Therapeutics, a biotechnology Read More
Terray Therapeutics and Calico Enter into a Multi-Target Collaboration to Discover Small Molecule Therapeutics for Age-Related Diseases
Collaboration combines Calico’s deep expertise in target biology with Terray’s proprietary drug discovery and development platform to identify novel therapeutics for patients affected by serious Read More
Terray Therapeutics Expands Scientific Advisory Board to Advance AI-Driven Small Molecule Drug Discovery
Fiona Black, PhD to join Terray’s Scientific Advisory Board PASADENA, Cali., July 12, 2022 – Terray Therapeutics, a biotechnology company propelling drug discovery into the Read More
Terray Therapeutics Expands Leadership Team with Fez Ujjainwalla, PhD as Head of Business
New appointment adds deep expertise in small molecule drug discovery, business development, and strategic partnerships Dr. Ujjainwalla joins an executive team of pioneers and long-time Read More
Terray Therapeutics Launches with $60M to Deliver Premium Chemical Data at Unrivaled Scale, Unlocking the Potential of AI-Driven Small Molecule Drug Discovery
tNova platform leverages the world’s most dense and precise microarray to discover and develop transformative therapeutics Series A Financing led by Madrona Venture Group with Read More

Contact Us